Enveric Biosciences, Inc. (ENVB)
1.41
-0.02
(-1.40%)
USD |
NASDAQ |
Aug 24, 16:00
1.48
+0.07
(+4.96%)
After-Hours: 20:00
Enveric Biosciences Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2019 | -27.90% |
| September 30, 2019 | 0.45% |
| June 30, 2019 | -11.41% |
| March 31, 2019 | -17.41% |
| December 31, 2018 | -192.2% |
| September 30, 2018 | 53.89% |
| June 30, 2018 | -11.38% |
| March 31, 2018 | -14.21% |
| December 31, 2017 | -8.94% |
| September 30, 2017 | -32.41% |
| June 30, 2017 | -26.61% |
| March 31, 2017 | -5.88% |
| December 31, 2016 | 10.53% |
| September 30, 2016 | -17.08% |
| June 30, 2016 | -18.08% |
| March 31, 2016 | -16.54% |
| December 31, 2015 | -23.11% |
| September 30, 2015 | -5.59% |
| June 30, 2015 | 2.82% |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 |
| Date | Value |
|---|---|
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 | |
| June 30, 2011 | |
| March 31, 2011 | |
| December 31, 2010 | |
| September 30, 2010 | |
| June 30, 2010 | |
| March 31, 2010 | |
| December 31, 2009 | |
| September 30, 2009 | |
| June 30, 2009 | |
| March 31, 2009 | |
| December 31, 2008 | |
| September 30, 2008 | |
| June 30, 2008 | |
| March 31, 2008 | |
| December 31, 2007 | |
| September 30, 2007 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| LENZ Therapeutics, Inc. | -581.8% |
| Impact BioMedical, Inc. | -23.33K% |
| ANI Pharmaceuticals, Inc. | 8.65% |
| Corcept Therapeutics, Inc. | 16.45% |
| Veru, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -190.1% |
| Return on Assets | -158.9% |
| Return on Invested Capital | -190.1% |
| Return on Net Operating Assets | -1.55K% |